HKSE - Delayed Quote HKD

King International Investment Limited (0928.HK)

0.076 +0.006 (+8.57%)
At close: 1:46 PM GMT+8
Loading Chart for 0928.HK
DELL
  • Previous Close 0.070
  • Open 0.079
  • Bid 0.072 x --
  • Ask 0.076 x --
  • Day's Range 0.073 - 0.080
  • 52 Week Range 0.070 - 0.640
  • Volume 464,000
  • Avg. Volume 611,914
  • Market Cap (intraday) 140.633M
  • Beta (5Y Monthly) 0.14
  • PE Ratio (TTM) --
  • EPS (TTM) -0.020
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

King International Investment Limited, an investment holding company, provides genetic testing and health data analysis services in the People's Republic of China and Hong Kong. The company operates through two segments, Healthcare Products and Services Business, and Money Lending Business. The company also engages in money lending activities. In addition, it provides corporate administrative and healthcare services. The company was formerly known as Life Healthcare Group Limited and changed its name to King International Investment Limited in December 2023. King International Investment Limited was incorporated in 2001 and is based in North Point, Hong Kong.

www.kinginternational.hk

31

Full Time Employees

March 31

Fiscal Year Ends

Related News

Performance Overview: 0928.HK

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

0928.HK
81.46%
HANG SENG INDEX
3.54%

1-Year Return

0928.HK
83.30%
HANG SENG INDEX
10.03%

3-Year Return

0928.HK
93.24%
HANG SENG INDEX
39.30%

5-Year Return

0928.HK
92.40%
HANG SENG INDEX
40.27%

Compare To: 0928.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0928.HK

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    129.53M

  • Enterprise Value

    135.08M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.43

  • Price/Book (mrq)

    0.55

  • Enterprise Value/Revenue

    0.54

  • Enterprise Value/EBITDA

    -5.12

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -8.86%

  • Return on Assets (ttm)

    -6.08%

  • Return on Equity (ttm)

    -11.88%

  • Revenue (ttm)

    250.87M

  • Net Income Avi to Common (ttm)

    -22.24M

  • Diluted EPS (ttm)

    -0.020

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    301k

  • Total Debt/Equity (mrq)

    2.51%

  • Levered Free Cash Flow (ttm)

    -107.81M

Company Insights: 0928.HK

People Also Watch